Pimicotinib was independently developed by Abbisko Therapeutics and has been licensed to Merck KGaA, Darmstadt, Germany, for worldwide commercialization. In December 2025, pimicotinib was approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback